Procalcitonin Antibiotic Consensus Trial (ProACT)
Public ClinicalTrials.gov record NCT02130986. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The ProACT study is a 5 year, multicenter study that will test the effect of implementation of a novel procalcitonin guideline on antibiotic use and adverse outcomes in Emergency Department (ED) patients with Lower Respiratory Tract Infection (LRTI).
Study identification
- NCT ID
- NCT02130986
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 1,664 participants
Conditions and interventions
Conditions
Interventions
- Procalcitonin level Other
- Results of procalcitonin (PCT) level to treating clinician Other
- Provide procalcitonin guideline to treating clinician Other
- Telephone Visit Other
Other
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 3, 2014 (Actual)
- Primary completion
- Jul 21, 2017 (Actual)
- Completion
- Jul 21, 2017 (Actual)
- Last update posted
- Jan 15, 2019
2014 – 2017
United States locations
- U.S. sites
- 13
- U.S. states
- 10
- U.S. cities
- 11
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Alabama at Birmingham | Birmingham | Alabama | 35249 | — |
| Maricopa Medical Center | Phoenix | Arizona | 85008 | — |
| University of California at Irvine Medical Center | Orange | California | 92868 | — |
| Norwalk Hospital | Norwalk | Connecticut | 06856 | — |
| University of Maryland/Baltimore | Baltimore | Maryland | 21201 | — |
| Massachusetts General Hospital | Boston | Massachusetts | 02114 | — |
| Brigham and Women's Hospital | Boston | Massachusetts | 02115 | — |
| Beth Israel Deaconess Medical Center | Boston | Massachusetts | 02215 | — |
| Wayne State University/Detroit Receiving Hospital | Detroit | Michigan | 48201 | — |
| Essentia Institute of Rural Health | Duluth | Minnesota | 55805 | — |
| The Ohio State University, College of Medicine | Columbus | Ohio | 43210 | — |
| Penn State Hershey College of Medicine; Milton S. Hershey Medical Center | Hershey | Pennsylvania | 17033 | — |
| University of Pittsburgh Medical Center | Pittsburgh | Pennsylvania | 15261 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02130986, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 15, 2019 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02130986 live on ClinicalTrials.gov.